Three primary subtypes can be identified: predominantly inattentive, hyperactive-impulsive, and combined presentations. It is characterised by difficulties in two subdomains: inattention, and hyperactivity-impulsivity.
Treatment with pharmacological and psychological interventions is expected to have a positive impact leading to increased productivity, decreased resource utilization and most importantly, improved long-term outcomes for girls and women.Īttention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition described in diagnostic classification systems (ICD-10, DSM-5 ). It is essential to adopt a lifespan model of care to support the complex transitions experienced by females that occur in parallel to change in clinical presentation and social circumstances. It is important to move away from the prevalent perspective that ADHD is a behavioural disorder and attend to the more subtle and/or internalised presentation that is common in females. This practical approach based upon expert consensus will inform effective identification, treatment and support of girls and women with ADHD. Furthermore, we determined the broader needs of these patients and considered how multi-agency liaison may provide the support to meet them.
These included symptomatic differences, gender biases, comorbidities and the compensatory strategies that may mask or overshadow underlying symptoms of ADHD. The potential challenges of working with this patient group were identified, as well as specific barriers that may hinder recognition. ResultsĪ consensus was reached offering practical guidance to support medical and mental health practitioners working with females with ADHD. The United Kingdom ADHD Partnership hosted a meeting of experts to discuss symptom presentation, triggers for referral, assessment, treatment and multi-agency liaison for females with ADHD across the lifespan. Comprehensive assessment and appropriate treatment is hoped to enhance longer-term clinical outcomes and patient wellbeing for females with ADHD. This consensus aims to provide a better understanding of females with ADHD in order to improve recognition and referral. Studies suggest that females with ADHD present with differences in their profile of symptoms, comorbidity and associated functioning compared with males. There is evidence to suggest that the broad discrepancy in the ratio of males to females with diagnosed ADHD is due, at least in part, to lack of recognition and/or referral bias in females.
0 kommentar(er)
